Arbutus Biopharma Corporation - Current Ratio

The Current Ratio as of June 2026 (TTM) for Arbutus Biopharma Corporation (ABUS) is 54.26

According to Arbutus Biopharma Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 54.26. This represents a change of 98.55% compared to the average of 27.33 of the last 4 quarters.

Arbutus Biopharma Corporation (ABUS) Historical Current Ratio (quarterly & annually)

How has ABUS Current Ratio performed in the past?

The mean historical Current Ratio of Arbutus Biopharma Corporation over the last ten years is 10.89. The current 54.26 Current Ratio has changed 49.72% with respect to the historical average. Over the past ten years (40 quarters), ABUS's Current Ratio was at its highest in in the March 2026 quarter at 54.26. The Current Ratio was at its lowest in in the December 2022 quarter at 4.60.

Arbutus Biopharma Corporation (ABUS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Arbutus Biopharma Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arbutus Biopharma Corporation (ABUS) Average Current Ratio

How has ABUS Current Ratio performed in the past?

The current Current Ratio of Arbutus Biopharma Corporation (ABUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arbutus Biopharma Corporation (ABUS) Current Ratio vs. Peers

How is ABUS’s Current Ratio compared to its peers?

Arbutus Biopharma Corporation’s Current Ratio is greater than ARS Pharmaceuticals, Inc. (4.94), greater than Nanobiotix S.A. (1.09), greater than GH Research PLC (23.04), greater than Tango Therapeutics, Inc. (27.38), greater than Bicara Therapeutics Inc. Common Stock (13.85), greater than Septerna, Inc. (4.71), greater than EyePoint Pharmaceuticals, Inc. (6.66), greater than Kura Oncology, Inc. (6.15), greater than ProKidney Corp. (9.06), greater than Savara Inc. (13.47),

Build a custom stock screener for Arbutus Biopharma Corporation (ABUS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arbutus Biopharma Corporation (ABUS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arbutus Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.